← Back to Patent Explorer
US4585651A Expired / Lapsed US ⏱️ 0.0 years remaining

Active/passive immunization of the internal female reproductive organs

Assignee: Alkermes Controlled Therapeutics Inc II
•
Filing: 1980-12-18
•
Granted: 1986-04-29
•
Expires: 2000-12-18
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Antibody or antigen containing microparticles for the active or passive immunization of the internal female reproductive organs, comprising: microparticles of an antigen or antibody incorporated in a matrix material which is biocompatible and biologically degradable, said microparticles capable of being transported after deposition in the vagina by the natural transport mechanism of the internal female reproductive organs across the cervix into the uterus.

Inventors

  • 👤 Lee R. Beck
  • 👤 Charles F. Flowers, Jr.
  • 👤 Donald R. Cowsar
  • 👤 Albert C. Tanquary

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 16:08
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/14; A61K9/16; A61K9/1605; A61K9/1629; A61K9/1641; A61K9/1647; A61K31/00; A61K31/56; A61K39/00; A61K9/0012; A61K9/0034; A61K9/0036; A61K9/1617; C; C07; C07K; C07K16/00; C12; C12N; C12N11/00; C12N11/02; C12N11/04; A61K38/00

Claims Analysis

Total Claims: 5
Claim 1
Independent Claim 63 words
A method of actively eliciting an immunization response of the internal female reproductive organs, comprising: depositing microparticles containing an antigen in the vagina; and allowing the natural transport mechanism of said organs to convey said microparticles across the cervix into the uterus and fallopian tubes, whereby said antigen is released by said microparticles so as to elicit an antibody response within the uterus.
Claim 2
Independent Claim 63 words
A method of actively eliciting an immunization response of the internal female reproductive organs, comprising: depositing microparticles containing an antigen in the vagina; and allowing the natural transport mechanism of said organs to convey said microparticles across the cervix into the uterus and fallopian tubes, whereby said antigen is released by said microparticles so as to elicit an antibody response within the uterus.
Claim 3
Dependent Claim 18 words
The method of claim 1, wherein said microparticles are of a size ranging from 20 to 70 μm.
Claim 4
Dependent Claim 17 words
The method of claim 1, wherein said matrix material is polylactic acid, polyglycolic acid or mixtures thereof.
Claim 5
Dependent Claim 14 words
The method of claim 1, wherein said antigen is of bacterial or viral origin.

References Cited (Backward Citations)

US3490454A Cited
US3691271A Cited
US3887699A Cited
US3594468A Cited
US3773919A Cited
US3755558A Cited
US3875300A Cited
US3921636A Cited
US3991766A Cited
US3918452A Cited
US4166800A Cited
WO1979000823A1 Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1989-04-28 1989-10-28 1990-04-29 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1993-04-28 1993-10-28 1994-04-29 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1997-04-28 1997-10-28 1998-04-29 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag